NKTX News and Press, Nkarta Inc. From 08/12/25

2025-08-12 16:51:51 ET More on Nkarta Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025 Seeking Alpha’s Quant Rating on Nkarta Historical earnings data for Nkarta Financial information for Nkarta Read the full article on...

Initial update for NKX019 in multiple autoimmune indications expected in second half of 2025 Cash balance of $334.0 million on June 30, 2025, including cash, cash equivalents and investments, expected to fund operations into 2029 SOUTH SAN FRANCISCO, Calif., Aug. 12, 2025 (GLOBE N...

Reeds Inc. (REED) is expected to report $-0.04 for Q2 2025 Jerash Holdings (US) Inc. (JRSH) is expected to report for Q1 2026 Churchill Capital Corp IX (CCIX) is expected to report for quarter end 2025-06-30 Verde Clean Fuels Inc. (VGAS) is expected to report for Q2 2025 Mobile In...

Nkarta Inc. (NKTX) is expected to report $-0.37 for Q2 2025

2025-08-11 18:45:12 ET Nkarta, Inc. (NKTX) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 1.62%. The average open to low on the day of earnings was -4.99%. The average open to close on ...

SOUTH SAN FRANCISCO, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the H.C. Wainwright “HCW@Home” Series. H.C Wain...

2025-07-22 00:40:53 ET Topline Summary and Update Read the full article on Seeking Alpha For further details see: Nkarta: Holding Its Support Steady Ahead Of First Data Readouts In 2025

SOUTH SAN FRANCISCO, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease, today announced the appointment of Shawn Rose, M.D. Ph.D., as its next Chief...

Replimune Group Inc. (REPL) is expected to report $-0.75 for Q4 2025 Adcore (ADCOF) is expected to report for Q1 2025 Equillium Inc. (EQ) is expected to report $-0.22 for Q1 2025 Credicorp Ltd. (BAP) is expected to report $5.31 for Q1 2025 Pelangio Exploration Inc (PGXPF) is expec...

2025-05-14 18:43:06 ET Nkarta, Inc. (NKTX) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in NKTX stock price following earnings has averaged ±1.31% , with a median of 1.05%. The sin...